Goldman Sachs’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-291,047
Closed -$7.89M 7582
2015
Q4
$7.89M Buy
291,047
+253,359
+672% +$6.53M ﹤0.01% 2439
2015
Q3
$824K Buy
37,688
+20,909
+125% +$534K ﹤0.01% 4666
2015
Q2
$478K Buy
16,779
+1,260
+8% +$36.7K ﹤0.01% 5256
2015
Q1
$424K Sell
15,519
-42,728
-73% -$1.18M ﹤0.01% 5302
2014
Q4
$1.54M Buy
58,247
+36,535
+168% +$1.07M ﹤0.01% 4119
2014
Q3
$655K Sell
21,712
-44,589
-67% -$1.38M ﹤0.01% 5030
2014
Q2
$2.09M Sell
66,301
-14,771
-18% -$469K ﹤0.01% 3954
2014
Q1
$2.62M Sell
81,072
-139,205
-63% -$4.87M ﹤0.01% 3713
2013
Q4
$8.01M Buy
220,277
+130,458
+145% +$5.07M ﹤0.01% 2579
2013
Q3
$3.49M Sell
89,819
-65,569
-42% -$2.64M ﹤0.01% 3341
2013
Q2
$5.82M Buy
+155,388
New +$6.14M ﹤0.01% 2591

Other funds holding MR

Goldman Sachs's MR Position: Q1 2016 in Review

Goldman Sachs sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 291,047 shares — an estimated $7.89M sold.

Goldman Sachs first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $8.01M in Q4 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Goldman Sachs reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Goldman Sachs sold 291,047 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $7.89M.
  • Goldman Sachs first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Goldman Sachs's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $8.01M in Q4 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.